4Moving Biotech

4Moving Biotech (4MB), a spin-off of 4P-Pharma, is a clinical-stage biotechnology company developing the first potential disease-modifying drug (DMOAD) for knee osteoarthritis. Their lead candidate, 4P004, is currently in a Phase 2a trial and aims to provide a sustainable therapeutic solution for the significant unmet medical need of osteoarthritis.

Funding Round: Grant

Funding Amount: €7.6M

Date: 08-Apr-2025

Investors: France 2030

Markets: Biotechnology, Pharmaceuticals, Research and Development, Osteoarthritis

HQ: Lille, Hauts-de-France, France

Founded: 2020

Website: https://www.4movingbiotech.com/

LinkedIn: https://www.linkedin.com/company/4moving-biotech

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/4moving-biotech?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase

Pitchbook: https://pitchbook.com/profiles/company/438509-17


Similar Startups


Leave a Comment

    🔷 Buy VC Database 🟩 Buy Startup Database 🎁 Get Free Sample

    Share this: